August 21, 2020
Digital Event: |
Overview:
Thom Busby, Vice President, Outcome Capital, moderates a panel event discussing the evolution of connected devices, featuring: Tyrone Heggins, BD; Greg Tracey, Propella Health; Dana Fashina, Verily Life Sciences For more information, please contact |
Blockbuster drug patent expiration, advances in enabling technology, and the emergence of personalized medicine for prostate cancer treatment create a landscape worth examining.
DownloadOutcome Capital Life Science Market Pulse March 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?